Results 31 to 40 of about 10,897 (217)
Chronic Inflammatory Demyelinating Polyneuropathy after ChAdOx1 nCoV-19 Vaccination
Vaccines, 2021 Recently several patients, who developed Guillain–Barré syndrome characterized by prominent bifacial weakness after ChAdOx1 nCoV-19 vaccination, were described from different centers. We recently observed a patient who developed a similar syndrome, later
Caterina Francesca Bagella +6 more
doaj +1 more source
Revista da Sociedade Brasileira de Medicina Tropical, 2010 A polineuropatia desmielinizante inflamatória cônica possui forte associação com a infecção pelo HIV e HCV. Uma rara associação entre PDIC e o tratamento da hepatite C com interferon peguilado alfa foi descrita recentemente.
Bil Randerson Bassetti +3 more
doaj +1 more source
Journal of Medical Case Reports, 2012 Introduction The combination of polyethylene glycol (PEG)ylated interferon (pegylated interferon) and ribavirin has been shown to be an effective treatment for chronic hepatitis C virus. In general, common side effects related to this combination therapy
Lahbabi Mounia +4 more
doaj +1 more source
Acute Onset Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19
Düzce Tıp Fakültesi Dergisi, 2022 The cases of Guillain Barre Syndrome (GBS) have been reported following the coronavirus disease 2019 (COVID-19). Here, we describe a case that evolved from GBS to chronic inflammatory demyelinating polyneuropathy (CIDP) after COVID-19 in terms of ...
Nilgün Çınar +4 more
doaj +1 more source
Медицинский совет, 2015 Paraproteinemic polyneuropathy accounts for up to 30% of chronic demyelinating polyneuropathies. The aim of this study was to determine the clinical and neurophysiological patterns of the nosology compared with chronic inflammatory demyelinating ...
M. A. Ginsberg +4 more
doaj +1 more source
Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
Case Reports in Neurology, 2020 Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated neuropathy that is characterized by a slowly progressive sensory and motor involvement lasting at least 2 months.
Alanood Alsolaihim, Steven K. Baker
doaj +1 more source
How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast
Neurology and Therapy, 2023 Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated neuropathy that typically presents with progressive or relapsing, symmetric, proximal, and distal weakness of upper and lower limbs, sensory involvement of at least ...
Urvi Desai
doaj +1 more source
Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy
Medicina, 2023 Background and Objectives: Studies have suggested that, by applying certain nerve ultrasound scores, demyelinating and axonal polyneuropathies can be differentiated.
Cheng-Yin Tan +3 more
doaj +1 more source
Clinical heterogeneity of chronic inflammatory demyelinating polyneuropathy: diagnostic challenges
Alʹmanah Kliničeskoj Mediciny, 2020 Сhronic inflammatory demyelinating polyneuropathy (CIDP) is the most prevalent acquired dysimmune neuropathy with clinical picture of symmetric motor and sensory disturbances.
A. S. Rizvanova +2 more
doaj +1 more source
Ultrasound neuroimaging in chronic inflammatory demyelinating polyneuropathy
Анналы клинической и экспериментальной неврологии, 2017 We present the results of ultrasound study of 21 patients withchronic inflammatory demyelinating polyneuropathy (CIDP).In 100% cases were observed changes of the ultrasound structureof peripheral nerves. The ultrasound abnormalities were mostprominent in
N. B. Vuytsik +4 more
doaj +1 more source